THE EFFECTS OF ARAMINE  (METARAMINOL) ON THE SPLANCHNIC, THE CARDIOPULMONARY AND THE SYSTEMIC CIRCULATION IN PATIENTS WITH MITRAL VALVULAR DISEASE.
D001281:Atrial Fibrillation; D001783:Blood Flow Velocity; D001786:Blood Glucose; D001794:Blood Pressure; D001795:Blood Pressure Determination; D001811:Blood Volume Determination; D002248:Carbon Monoxide; D006328:Cardiac Catheterization; D004395:Dye Dilution Technique; D006349:Heart Valve Diseases; D006400:Hematocrit; D006503:Hepatic Veins; D006801:Humans; D008680:Metaraminol; D008943:Mitral Valve; D008944:Mitral Valve Insufficiency; D013448:Sulfobromophthalein
D001786:Blood Glucose; D013448:Sulfobromophthalein; D002248:Carbon Monoxide; D008680:Metaraminol
AURICULAR FIBRILLATION; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD SUGAR; BLOOD VOLUME DETERMINATION; CARBON MONOXIDE; DYE DILUTION TECHNIC; HEART CATHETERIZATION; HEMATOCRIT; HEPATIC VEINS; METARAMINOL; MITRAL VALVE INSUFFICIENCY; SULFOBROMOPHTHALEIN